Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.

Müller M, Mazur AJ, Behrmann E, Diensthuber RP, Radke MB, Qu Z, Littwitz C, Raunser S, Schoenenberger CA, Manstein DJ, Mannherz HG.

Cell Mol Life Sci. 2012 Oct;69(20):3457-79. doi: 10.1007/s00018-012-1030-5. Epub 2012 May 29.

PMID:
22643837
[PubMed - indexed for MEDLINE]
3.

Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.

Debold EP, Saber W, Cheema Y, Bookwalter CS, Trybus KM, Warshaw DM, Vanburen P.

J Mol Cell Cardiol. 2010 Feb;48(2):286-92. doi: 10.1016/j.yjmcc.2009.09.014. Epub 2009 Sep 30.

PMID:
19799913
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.

Flavigny J, Souchet M, Sébillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L.

J Mol Biol. 1999 Nov 26;294(2):443-56.

PMID:
10610770
[PubMed - indexed for MEDLINE]
5.

Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with cardiomyopathies.

Chow ML, Shaffer JF, Harris SP, Dawson JF.

Arch Biochem Biophys. 2014 May 15;550-551:28-32. doi: 10.1016/j.abb.2014.04.003. Epub 2014 Apr 13.

PMID:
24736382
[PubMed - indexed for MEDLINE]
6.

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.

Robinson P, Griffiths PJ, Watkins H, Redwood CS.

Circ Res. 2007 Dec 7;101(12):1266-73. Epub 2007 Oct 11.

PMID:
17932326
[PubMed - indexed for MEDLINE]
Free Article
7.

Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.

Redwood C, Lohmann K, Bing W, Esposito GM, Elliott K, Abdulrazzak H, Knott A, Purcell I, Marston S, Watkins H.

Circ Res. 2000 Jun 9;86(11):1146-52.

PMID:
10850966
[PubMed - indexed for MEDLINE]
Free Article
8.

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].

Borovikov IuS, Karpicheva OE, Rysev NA, Redwood CS.

Ross Fiziol Zh Im I M Sechenova. 2013 Jan;99(1):73-80. Russian.

PMID:
23659058
[PubMed - indexed for MEDLINE]
9.

Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.

Roopnarine O, Leinwand LA.

Biophys J. 1998 Dec;75(6):3023-30.

PMID:
9826622
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Functional consequences of a mutation in an expressed human alpha-cardiac actin at a site implicated in familial hypertrophic cardiomyopathy.

Bookwalter CS, Trybus KM.

J Biol Chem. 2006 Jun 16;281(24):16777-84. Epub 2006 Apr 12.

PMID:
16611632
[PubMed - indexed for MEDLINE]
Free Article
11.

Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants.

Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg KS, Eschenhagen T, Zolk O.

Cardiovasc Res. 2005 Apr 1;66(1):33-44.

PMID:
15769446
[PubMed - indexed for MEDLINE]
Free Article
12.

The effect of the Asp175Asn and Glu180Gly TPM1 mutations on actin-myosin interaction during the ATPase cycle.

Rysev NA, Karpicheva OE, Redwood CS, Borovikov YS.

Biochim Biophys Acta. 2012 Feb;1824(2):366-73. doi: 10.1016/j.bbapap.2011.11.004. Epub 2011 Dec 3.

PMID:
22155441
[PubMed - indexed for MEDLINE]
Free Article
14.

Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.

Lin D, Bobkova A, Homsher E, Tobacman LS.

J Clin Invest. 1996 Jun 15;97(12):2842-8.

PMID:
8675696
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.

Karibe A, Tobacman LS, Strand J, Butters C, Back N, Bachinski LL, Arai AE, Ortiz A, Roberts R, Homsher E, Fananapazir L.

Circulation. 2001 Jan 2;103(1):65-71.

PMID:
11136687
[PubMed - indexed for MEDLINE]
Free Article
16.

Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.

Davis J, Wen H, Edwards T, Metzger JM.

J Mol Cell Cardiol. 2008 May;44(5):891-904. doi: 10.1016/j.yjmcc.2008.02.274. Epub 2008 Feb 26.

PMID:
18423659
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Contractility-dependent actin dynamics in cardiomyocyte sarcomeres.

Skwarek-Maruszewska A, Hotulainen P, Mattila PK, Lappalainen P.

J Cell Sci. 2009 Jun 15;122(Pt 12):2119-26. doi: 10.1242/jcs.046805. Epub 2009 May 26.

PMID:
19470580
[PubMed - indexed for MEDLINE]
Free Article
18.

A re-evaluation of cytoplasmic gelsolin localization.

Carron CP, Hwo SY, Dingus J, Benson DM, Meza I, Bryan J.

J Cell Biol. 1986 Jan;102(1):237-45.

PMID:
3001100
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.

Bing W, Redwood CS, Purcell IF, Esposito G, Watkins H, Marston SB.

Biochem Biophys Res Commun. 1997 Jul 30;236(3):760-4.

PMID:
9245729
[PubMed - indexed for MEDLINE]
20.

Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation.

Vang S, Corydon TJ, Børglum AD, Scott MD, Frydman J, Mogensen J, Gregersen N, Bross P.

FEBS J. 2005 Apr;272(8):2037-49.

PMID:
15819894
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk